ReProtect, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm
Phase 2
Completed
- Conditions
- Contraception
- First Posted Date
- 2006-11-09
- Last Posted Date
- 2006-11-09
- Lead Sponsor
- ReProtect Inc
- Target Recruit Count
- 200
- Registration Number
- NCT00397670
© Copyright 2025. All Rights Reserved by MedPath